SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.84-1.7%Jan 16 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (22707)6/25/1998 10:27:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Actually, all of the androgen data is pre-clinical (IND expected later this year with trials beginning early next year), but the markets are huge and at this time it's all LGND. Not sure if they will partner some of this out, but they are making remarkable progress in many areas and unlike the SERMs (where LGND has programs with LLY on Evista, PFE on Droloxifene and CP-366,156, and AHP on TSE424), so far LGND has grabbed the ball and is running with it on the SARMs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News